주식/증권
📈 긍정적
INSP Stock Rallies Nearly 40% YTD: Can Its Growth Story Continue?
요약
Inspire Medical stock's 39.7% three-month surge is driven by the easing of reimbursement pressures, increasing Inspire V adoption and Project Horizon targeting longer-term expansion.